This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,080.62 and an ultimate completion date of December 10, 2024. This contract is not associated with any set-aside designation, indicating that it was competed in the open market. The contract supports medical readiness initiatives for the Department of Defense, providing essential pharmaceutical products to military healthcare operations. Eagle Pharmaceuticals also holds a significant Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) Veterans Health Administration, valued at $30,890,560 and effective from February 2024 through January 2029, which enables the VA and DLA to efficiently procure the company's pharmaceutical products.
Generated 3/6/25, 10:15 AM